Skip to content
1st Counsel – Lifestyle
Author:
Beam Therapeutics
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026
May 12, 2026
←
Previous Page
1
2